These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3543636)

  • 1. Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol.
    Felsenfeld AJ; Gutman RA; Drezner M; Llach F
    Miner Electrolyte Metab; 1986; 12(5-6):333-41. PubMed ID: 3543636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA; Horst RL; Hawker CD
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY; Hwang EA; Park SB; Kim HC; Kim HT
    Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.
    Rolla D; Ballanti P; Marsano L; Bianchi G; Messa P; Paoletti E; Cannella G
    Transplantation; 2006 Mar; 81(6):915-21. PubMed ID: 16570017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phosphorus metabolism in stable renal transplant recipients.
    Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
    Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients.
    Steiner RW; Ziegler M; Halasz NA; Catherwood BD; Manolagas S; Deftos LJ
    Transplantation; 1993 Oct; 56(4):843-6. PubMed ID: 8212205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 1,25-dihydroxycholecalciferol, parathyroid hormone, and thyroxine on trabecular bone remodeling in adult dogs. A histomorphometric study.
    High WB; Capen CC; Black HE
    Am J Pathol; 1981 Dec; 105(3):279-87. PubMed ID: 6895577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
    Parfitt AM; Kleerekoper M; Cruz C
    Miner Electrolyte Metab; 1986; 12(5-6):356-62. PubMed ID: 3543637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus].
    Dumas R; Guermoud C; Garabedian M; Meunier JP
    Arch Fr Pediatr; 1985; 42(7):507-10. PubMed ID: 3002291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone gene expression in hypophosphatemic rats.
    Kilav R; Silver J; Naveh-Many T
    J Clin Invest; 1995 Jul; 96(1):327-33. PubMed ID: 7615802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.